Kimberly Clark Corp (KMB) · Oct 29, 2026 · New debt
$4.9B debt issuance — $4.9B across five note tranches at 5.100%-5.800%
Kimberly-Clark’s debt filing puts $4.9B of Kenvue acquisition financing on paper, with notes maturing from 2028 through 2036.
Kimberly-Clark is moving from planning to execution on its pending Kenvue acquisition, a transaction intended to broaden the company from consumer staples into a larger health-and-wellness platform. The merger remains expected in the fourth quarter of 2026, while the company has been preparing integration leadership and regulatory approvals.
The acquisition financing is now concrete. The registration-rights agreement supports the sale of $4.9 billion of senior notes across five maturities, giving Kimberly-Clark a defined debt package to fund the Kenvue transaction. The filing also links the notes to the parallel exchange of Kenvue’s existing bonds. 〔0〕
| Debt tranche (Debt terms) | Principal | Coupon | Maturity |
|---|---|---|---|
| 2028 Notes (Debt terms) | $750M | 5.100% | 2028 |
| 2029 Notes (Debt terms) | $1,000M | 5.300% | 2029 |
| 2031 Notes (Debt terms) | $1,250M | 5.450% | 2031 |
| 2034 Notes (Debt terms) | $750M | 5.650% | 2034 |
| 2036 Notes (Debt terms) | $1,150M | 5.800% | 2036 |
| Total (Debt terms) | $4,900M |
This advances the deal, but it also hardens the leverage burden. The notes provide funding certainty for the largest strategic transaction in Kimberly-Clark’s current story, but the 5.1%-to-5.8% coupons imply a meaningful recurring interest obligation before any promised Kenvue synergies arrive. The filing does not provide updated leverage, ratings, or pro forma cash-flow targets, so the balance-sheet impact cannot be judged more precisely here.
The financing itself is not a major surprise. The merger and its expected second-half-2026 closing were already public, and the purchase agreement underlying these notes was dated October 19, 2026. The new information is the exact tranche structure, maturities, and borrowing costs—not the decision to use debt.
Registration rights reduce a technical friction point for bondholders. Kimberly-Clark must use commercially reasonable efforts to launch an exchange offer for unrestricted replacement notes and complete it within 365 days after the merger closes; if it fails, the notes can become subject to shelf-registration obligations and additional interest of 0.25%, rising to 0.50%. 〔1〕
Bottom line: This is an execution step, not a new strategic surprise: Kimberly-Clark has put the debt funding for Kenvue on paper. It advances closing certainty while making the cost and balance-sheet burden of the acquisition more tangible. ا
Kenvue merger closing, Q4 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!